Summary by Futu AI
Allarity Therapeutics, Inc. (Allarity) has announced an offering of up to 26,569,246 shares of common stock, alongside an equal number of Series A and Series B common warrants, and pre-funded warrants to purchase shares of common stock. The offering also includes up to 53,138,492 shares of common stock issuable upon the exercise of Series A and Series B common warrants, and up to 26,569,246 shares of common stock issuable upon the exercise of pre-funded warrants. The exercise price for the warrants will be determined based on the public offering price of the shares. The securities are being offered through a placement agent on a reasonable best-efforts basis. The placement agent is not purchasing the securities but will attempt to arrange...Show More